0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover698.36%IV-71.06%PremiumDec 20, 2024Expiry Date12.28Intrinsic Value100Multiplier8DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9562Delta0.0051Gamma1.35Leverage Ratio-0.1020Theta0.0008Rho1.29Eff Leverage0.0024Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet